These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3935 related articles for article (PubMed ID: 7040766)

  • 1. B16 melanoma cell variants: irreversible inhibition of growth and induction of morphologic differentiation by anthracycline antibiotics.
    Raz A
    J Natl Cancer Inst; 1982 Apr; 68(4):629-38. PubMed ID: 7040766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
    Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
    Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells.
    Oh JW; Katz A; Harroch S; Eisenbach L; Revel M; Chebath J
    Oncogene; 1997 Jul; 15(5):569-77. PubMed ID: 9247310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tertiary amine local anesthetics on the blood-borne implantation and cell surface properties of metastatic mouse melanoma cells.
    Nicolson GL; Fidler IJ; Poste G
    J Natl Cancer Inst; 1986 Mar; 76(3):511-9. PubMed ID: 3456465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro inhibition of B16 melanoma growth by vitamin B6.
    DiSorbo DM; Wagner R; Nathanson L
    Nutr Cancer; 1985; 7(1-2):43-52. PubMed ID: 4070008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined activity of interleukin-1 alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects.
    Borsellino N; Crescimanno M; Flandina C; Flugy A; D'Alessandro N
    Anticancer Res; 1994; 14(6B):2643-8. PubMed ID: 7872695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of NSC-631570 (ukrain) alone and in combination with pathogen-associated molecules on cell cycle distribution and apoptosis induction of mouse melanoma cells with different biological properties.
    Skivka LM; Trompak OO; Kudryavets YI; Bezdenezhnykh NA; Susak YM
    Exp Oncol; 2010 Jul; 32(2):92-6. PubMed ID: 20693969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
    Fidler IJ; Nicolson GL
    Isr J Med Sci; 1978 Jan; 14(1):38-50. PubMed ID: 632082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-trifluoroacetyladriamycin-14-valerate and related agents on DNA strand damage and thymidine incorporation in CCRF-CEM cells.
    Kanter PM; Schwartz HS
    Cancer Res; 1979 Feb; 39(2 Pt 1):448-51. PubMed ID: 761217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of retinoids on growth and melanin content of Harding-Passey-melanoma cells in vitro and B16 transplantable melanoma in vivo.
    Drewa G; Schachtschabel DO
    Arch Geschwulstforsch; 1985; 55(2):93-8. PubMed ID: 4004512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth characteristics of clonal cell populations constituting a B16 melanoma metastasis model system.
    Stackpole CW; Alterman AL; Fornabaio DM
    Invasion Metastasis; 1985; 5(3):125-43. PubMed ID: 3888909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and B16 melanoma resistant to doxorubicin.
    Berezhnaya NM; Vinnichuk YD; Belova OB
    Exp Oncol; 2008 Mar; 30(1):52-5. PubMed ID: 18438341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.
    Kanter PM; Schwartz HS
    Cancer Res; 1979 Sep; 39(9):3661-72. PubMed ID: 476691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture.
    Prasad KN; Edwards-Prasad J
    Cancer Res; 1982 Feb; 42(2):550-5. PubMed ID: 6275980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 197.